Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 106 AL 120

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies

Ivanoiu A, Pariente J, Booth K, Lobello K, Luscan G, Hua L, Lucas P, Styren S, Yang L, Li D, Black RS, Brashear HR, McRae T.

Alzheimers Res Ther. 2016 Jun 23;8(1):24. doi: 10.1186/s13195-016-0193-y.

Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review

Klimova B, Kuca K.

Curr Alzheimer Res. 2016;13(12):1312-1318. doi: 10.2174/1567205013666160603000623.

Folic Acid Supplementation Mitigates Alzheimer's Disease by Reducing Inflammation: A Randomized Controlled Trial

Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y, Zheng M, Zhang M, Xu W, Huang G.

Mediators Inflamm. 2016;2016:5912146. doi: 10.1155/2016/5912146. Epub 2016 Jun 2.

Effect of aerobic exercise on physical performance in patients with Alzheimer's disease

Sobol NA, Hoffmann K, Frederiksen KS, Vogel A, Vestergaard K, Brændgaard H, Gottrup H, Lolk A, Wermuth L, Jakobsen S, Laugesen L, Gergelyffy R, Høgh P, Bjerregaard E, Siersma V, Andersen BB, Johannsen P, Waldemar G, Hasselbalch SG, Beyer N.

Alzheimers Dement. 2016 Dec;12(12):1207-1215. doi: 10.1016/j.jalz.2016.05.004. Epub 2016 Jun 23.

Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials

Tsoi KK, Chan JY, Leung NW, Hirai HW, Wong SY, Kwok TC.

J Am Med Dir Assoc. 2016 Sep 1;17(9):863.e1-8. doi: 10.1016/j.jamda.2016.05.015. Epub 2016 Jun 24.

Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment

Montoliu-Gaya L, Villegas S.

Expert Rev Mol Med. 2016 Jun 30;18:e13. doi: 10.1017/erm.2016.11.

POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION

Zheng C, Lan Y, Zhang J, Zhang L, Wu J, Guo S.

Acta Pol Pharm. 2016 Jul;73(4):835-842.

Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

Cynis H, Frost JL, Crehan H, Lemere CA.

Mol Neurodegener. 2016 Jun 30;11(1):48. doi: 10.1186/s13024-016-0115-2.

Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases

Sadek B, Saad A, Sadeq A, Jalal F, Stark H.

Behav Brain Res. 2016 Oct 1;312:415-30. doi: 10.1016/j.bbr.2016.06.051. Epub 2016 Jun 27.

Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease

Salem H, Rocha NP, Colpo GD, Teixeira AL.

J Alzheimers Dis. 2016 Jul 2;53(3):1209-30. doi: 10.3233/JAD-160250.

Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis

Penninkilampi R, Brothers HM, Eslick GD.

J Alzheimers Dis. 2016 Jul 6;53(4):1395-404. doi: 10.3233/JAD-160275.

Deep Brain Stimulation of the Fornix: Engaging Therapeutic Circuits and Networks in Alzheimer Disease

Rowland NC, Sammartino F, Tomaszczyk JC, Lozano AM.

Neurosurgery. 2016 Aug;63 Suppl 1:1-5. doi: 10.1227/NEU.0000000000001254.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias